Ritu Baral
Stock Analyst at TD Cowen
(4.97)
# 65
Out of 5,005 analysts
1045
Total ratings
53.1%
Success rate
43.9%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTC Benitec Biopharma | Maintained: Buy | n/a | $11.05 | - | 6 | Sep 16, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $71 | $50.00 | +42.00% | 6 | Sep 14, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $78 | $33.67 | +131.66% | 27 | Aug 31, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | n/a | $2.71 | - | 25 | Aug 13, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.9277 | +762.35% | 36 | Aug 12, 2026 | |
| NGNE Neurogene | Reiterated: Buy | n/a | $33.69 | - | 24 | Aug 11, 2026 | |
| VTVT vTv Therapeutics | Reiterated: Buy | $67 | $30.46 | +119.96% | 4 | Aug 7, 2026 | |
| GHRS GH Research | Reiterated: Buy | n/a | $27.55 | - | 15 | Aug 6, 2026 | |
| INSM Insmed | Reiterated: Buy | $243 | $119.92 | +102.64% | 73 | Aug 6, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | n/a | $5.82 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $510 | $312.90 | +62.99% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 | $20.72 | -17.95% | 104 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 | $26.76 | +38.27% | 66 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $13.81 | +109.99% | 23 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $267 | $151.22 | +76.56% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $403 | $336.68 | +19.70% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $482 | $238.27 | +102.29% | 101 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.86 | +159.07% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $644 | $523.26 | +23.07% | 45 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.88 | - | 9 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $18.57 | +147.71% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €8.67 | €3.44 | +152.28% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.25 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $10.46 | +100.76% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.13 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.22 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.1473 | n/a | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.6705 | n/a | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.36 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.12 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20.75 → $20.41 | $2.20 | n/a | 7 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $55.17 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.51 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $47.25 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.80 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $65.65 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.07 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.10 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.62 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.37 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $69.31 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.83 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.60 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.26 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $1.76 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $216.17 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $13.93 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.000001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.66 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.19 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $17.17 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.85 | n/a | 1 | Feb 21, 2012 |
Benitec Biopharma
Sep 16, 2026
Maintained: Buy
Price Target: n/a
Current: $11.05
Upside: -
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $71
Current: $50.00
Upside: +42.00%
Vera Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $78
Current: $33.67
Upside: +131.66%
Ovid Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.71
Upside: -
Milestone Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9277
Upside: +762.35%
Neurogene
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.69
Upside: -
vTv Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $67
Current: $30.46
Upside: +119.96%
GH Research
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.55
Upside: -
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $243
Current: $119.92
Upside: +102.64%
Opus Genetics
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.82
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $510
Current: $312.90
Upside: +62.99%
Aug 6, 2026
Rated: Hold
Price Target: $17
Current: $20.72
Upside: -17.95%
Aug 5, 2026
Rated: Buy
Price Target: $37
Current: $26.76
Upside: +38.27%
Aug 5, 2026
Reiterated: Buy
Price Target: $29
Current: $13.81
Upside: +109.99%
Aug 4, 2026
Reiterated: Buy
Price Target: $267
Current: $151.22
Upside: +76.56%
Aug 3, 2026
Reiterated: Buy
Price Target: $403
Current: $336.68
Upside: +19.70%
Jul 31, 2026
Rated: Buy
Price Target: $482
Current: $238.27
Upside: +102.29%
Jul 31, 2026
Reiterated: Buy
Price Target: $10
Current: $3.86
Upside: +159.07%
Jul 30, 2026
Reiterated: Buy
Price Target: $644
Current: $523.26
Upside: +23.07%
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.88
Upside: -
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $18.57
Upside: +147.71%
Jun 8, 2026
Reiterated: Buy
Price Target: €8.67
Current: €3.44
Upside: +152.28%
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.25
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $21
Current: $10.46
Upside: +100.76%
Nov 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.13
Upside: -
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.22
Upside: -
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.1473
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.6705
Upside: n/a
Apr 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $5.36
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.12
Upside: n/a
Apr 18, 2023
Downgraded: Hold
Price Target: $20.75 → $20.41
Current: $2.20
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $55.17
Upside: n/a
Mar 16, 2020
Reiterated: Buy
Price Target: n/a
Current: $28.51
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: n/a
Current: $47.25
Upside: n/a
Feb 24, 2020
Reiterated: Buy
Price Target: n/a
Current: $18.80
Upside: n/a
May 8, 2019
Reiterated: Hold
Price Target: n/a
Current: $65.65
Upside: n/a
Jan 6, 2019
Reiterated: Buy
Price Target: n/a
Current: $13.07
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $43.10
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.62
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $69.31
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $21.83
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $4.60
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $5.26
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $1.76
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $216.17
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $13.93
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.000001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.66
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.19
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $17.17
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $7.85
Upside: n/a